{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T04:49:58Z","timestamp":1782967798639,"version":"3.54.5"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T00:00:00Z","timestamp":1743811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T00:00:00Z","timestamp":1743811200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e0 degli Studi di Roma La Sapienza"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Although direct oral anticoagulants (DOACs) are non-inferior to Vitamin K antagonists (VKA) in preventing ischemic stroke (IS) in atrial fibrillation (AF) patients, there are limited data regarding stroke severity and prognosis of patients admitted with IS during DOAC treatment. We performed a single center retrospective study including patients with AF on oral anticoagulants admitted to the Emergency Department for IS were included. The primary endpoint was to analyse the severity of stroke evaluated through NIHSS scale according to anticoagulant therapy. The secondary endpoint was 3-month all-cause mortality. A total of 106 AF patients were included, with a mean age of 81.3\u2009\u00b1\u20097.5 years. Overall, 54.7% were women and 61.3% on DOAC. The AF patients on DOAC were older, with no other clinical differences. Median NIHSS was 12 (Interquartile Range [IQR] 5\u201319). At multivariable logistic regression analysis DOAC use (compared to warfarin) was associated with lower risk of moderate-severe\/severe stroke (NIHSS\u2009\u2265\u200916) (Odds Ratio [OR] 0.355, 95% confidence interval [95% CI] 0.127\u20130.995). Mechanical thrombectomy was strongly associated with higher severity of stroke (OR 6.113, 95%CI 2.186\u201317.099). During follow-up, 42 patients died. DOAC use inversely correlated with mortality risk (OR 0.323, 95%CI 0.127\u20130.822) after adjusting for CHA<jats:sub>2<\/jats:sub>DS<jats:sub>2<\/jats:sub>-VASc, time to hospital admission from symptom onset and type of acute treatment. In conclusion, in our contemporary real-world population, patients on DOACs treatment admitted for IS had better outcomes in terms of stroke severity and all-cause mortality compared with patients on VKAs.<\/jats:p>\n          <jats:p>\n            <jats:bold>Graphical Abstract<\/jats:bold>\n          <\/jats:p>","DOI":"10.1007\/s11239-025-03095-1","type":"journal-article","created":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T02:49:19Z","timestamp":1743907759000},"page":"576-584","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The severity of ischemic stroke and risk of all-cause mortality in patients with atrial fibrillation on different oral anticoagulant treatments admitted to the emergency department"],"prefix":"10.1007","volume":"58","author":[{"given":"Tommasa","family":"Vicario","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danilo","family":"Menichelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo Paolo","family":"Mascolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Diomedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Cerretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Marconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Pignatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Paganelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Pastori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,5]]},"reference":[{"issue":"10","key":"3095_CR1","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1161\/CIR.0000000000000659","volume":"139","author":"EJ Benjamin","year":"2019","unstructured":"Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP et al (2019) Heart disease and stroke Statistics-2019 update: A report from the American heart association. Circulation 139(10):e56\u2013e528. https:\/\/doi.org\/10.1161\/CIR.0000000000000659","journal-title":"Circulation"},{"issue":"8","key":"3095_CR2","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.113.005119","volume":"129","author":"SS Chugh","year":"2014","unstructured":"Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EJ et al (2014) Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study. Circulation 129(8):837\u2013847. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.113.005119","journal-title":"Circulation"},{"issue":"2","key":"3095_CR3","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1161\/STROKEAHA.113.003433","volume":"45","author":"A Kishore","year":"2014","unstructured":"Kishore A, Vail A, Majid A, Dawson J, Lees KR, Tyrrell PJ et al (2014) Detection of atrial fibrillation after ischemic stroke or transient ischemic attack: a systematic review and meta-analysis. Stroke 45(2):520\u2013526. https:\/\/doi.org\/10.1161\/STROKEAHA.113.003433","journal-title":"Stroke"},{"issue":"4","key":"3095_CR4","doi-asserted-by":"publisher","first-page":"e022638","DOI":"10.1161\/JAHA.121.022638","volume":"11","author":"NE Vinding","year":"2022","unstructured":"Vinding NE, Kristensen SL, Rorth R, Butt JH, Ostergaard L, Olesen JB et al (2022) Ischemic stroke severity and mortality in patients with and without atrial fibrillation. J Am Heart Assoc 11(4):e022638. https:\/\/doi.org\/10.1161\/JAHA.121.022638","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"3095_CR5","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"G Hindricks","year":"2021","unstructured":"Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomstrom-Lundqvist C et al (2021) 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European association for Cardio-Thoracic surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European society of cardiology (ESC) developed with the special contribution of the European heart rhythm association (EHRA) of the ESC. Eur Heart J 42(5):373\u2013498. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa612","journal-title":"Eur Heart J"},{"issue":"9921","key":"3095_CR6","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","volume":"383","author":"CT Ruff","year":"2014","unstructured":"Ruff CT, Giugliano RP, Braunwald E, Hoffman EB, Deenadayalu N, Ezekowitz MD et al (2014) Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet 383(9921):955\u2013962. https:\/\/doi.org\/10.1016\/S0140-6736(13)62343-0","journal-title":"Lancet"},{"issue":"3","key":"3095_CR7","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.mayocp.2020.06.057","volume":"96","author":"D Pastori","year":"2021","unstructured":"Pastori D, Menichelli D, Del Sole F, Pignatelli P, Violi F, group A-As (2021) Long-Term risk of major adverse cardiac events in atrial fibrillation patients on direct oral anticoagulants. Mayo Clin Proc 96(3):658\u2013665. https:\/\/doi.org\/10.1016\/j.mayocp.2020.06.057","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"3095_CR8","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/ana.25917","volume":"89","author":"TR Meinel","year":"2021","unstructured":"Meinel TR, Branca M, De Marchis GM, Nedeltchev K, Kahles T, Bonati L et al (2021) Prior anticoagulation in patients with ischemic stroke and atrial fibrillation. Ann Neurol 89(1):42\u201353. https:\/\/doi.org\/10.1002\/ana.25917","journal-title":"Ann Neurol"},{"issue":"9","key":"3095_CR9","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1007\/s00415-019-09412-y","volume":"266","author":"E Auer","year":"2019","unstructured":"Auer E, Frey S, Kaesmacher J, Hakim A, Seiffge DJ, Goeldlin M et al (2019) Stroke severity in patients with preceding direct oral anticoagulant therapy as compared to vitamin K antagonists. J Neurol 266(9):2263\u20132272. https:\/\/doi.org\/10.1007\/s00415-019-09412-y","journal-title":"J Neurol"},{"issue":"2","key":"3095_CR10","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1007\/s11239-022-02680-y","volume":"54","author":"P Krieger","year":"2022","unstructured":"Krieger P, Melmed KR, Torres J, Zhao A, Croll L, Irvine H et al (2022) Pre-admission antithrombotic use is associated with 3-month mRS score after thrombectomy for acute ischemic stroke. J Thromb Thrombolysis 54(2):350\u2013359. https:\/\/doi.org\/10.1007\/s11239-022-02680-y","journal-title":"J Thromb Thrombolysis"},{"issue":"7","key":"3095_CR11","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S1474-4422(13)70055-3","volume":"12","author":"J Alvarez-Sabin","year":"2013","unstructured":"Alvarez-Sabin J, Maisterra O, Santamarina E, Kase CS (2013) Factors influencing haemorrhagic transformation in ischaemic stroke. Lancet Neurol 12(7):689\u2013705. https:\/\/doi.org\/10.1016\/S1474-4422(13)70055-3","journal-title":"Lancet Neurol"},{"issue":"7","key":"3095_CR12","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1161\/STR.0b013e318296aeca","volume":"44","author":"RL Sacco","year":"2013","unstructured":"Sacco RL, Kasner SE, Broderick JP, Caplan LR, Connors JJ, Culebras A et al (2013) An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American heart association\/american stroke association. Stroke 44(7):2064\u20132089. https:\/\/doi.org\/10.1161\/STR.0b013e318296aeca","journal-title":"Stroke"},{"issue":"12","key":"3095_CR13","doi-asserted-by":"publisher","first-page":"e344","DOI":"10.1161\/STR.0000000000000211","volume":"50","author":"WJ Powers","year":"2019","unstructured":"Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K et al (2019) Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: A guideline for healthcare professionals from the American heart association\/american stroke association. Stroke 50(12):e344\u2013e418. https:\/\/doi.org\/10.1161\/STR.0000000000000211","journal-title":"Stroke"},{"issue":"1","key":"3095_CR14","doi-asserted-by":"publisher","first-page":"I","DOI":"10.1177\/2396987321989865","volume":"6","author":"E Berge","year":"2021","unstructured":"Berge E, Whiteley W, Audebert H, De Marchis GM, Fonseca AC, Padiglioni C et al (2021) European stroke organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke. Eur Stroke J 6(1):I\u2013LXII. https:\/\/doi.org\/10.1177\/2396987321989865","journal-title":"Eur Stroke J"},{"issue":"12","key":"3095_CR15","doi-asserted-by":"publisher","first-page":"3331","DOI":"10.1161\/STROKEAHA.119.027708","volume":"50","author":"JJ Warner","year":"2019","unstructured":"Warner JJ, Harrington RA, Sacco RL, Elkind MSV (2019) Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke. Stroke 50(12):3331\u20133332. https:\/\/doi.org\/10.1161\/STROKEAHA.119.027708","journal-title":"Stroke"},{"issue":"10","key":"3095_CR16","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1093\/europace\/euab065","volume":"23","author":"J Steffel","year":"2021","unstructured":"Steffel J, Collins R, Antz M, Cornu P, Desteghe L, Haeusler KG et al (2021) 2021 European heart rhythm association practical guide on the use of Non-Vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Europace 23(10):1612\u20131676. https:\/\/doi.org\/10.1093\/europace\/euab065","journal-title":"Europace"},{"key":"3095_CR17","doi-asserted-by":"publisher","unstructured":"Schlegel D, Kolb SJ, Luciano JM, Tovar JM, Cucchiara BL, Liebeskind DS et al (2003) Utility of the NIH Stroke Scale as a predictor of hospital disposition. Stroke 34(1):134\u20137. https:\/\/doi.org\/10.1161\/01.str.0000048217.44714.02","DOI":"10.1161\/01.str.0000048217.44714.02"},{"issue":"1","key":"3095_CR18","doi-asserted-by":"publisher","first-page":"e0147287","DOI":"10.1371\/journal.pone.0147287","volume":"11","author":"CK Bush","year":"2016","unstructured":"Bush CK, Kurimella D, Cross LJ, Conner KR, Martin-Schild S, He J et al (2016) Endovascular treatment with Stent-Retriever devices for acute ischemic stroke: A Meta-Analysis of randomized controlled trials. PLoS ONE 11(1):e0147287. https:\/\/doi.org\/10.1371\/journal.pone.0147287","journal-title":"PLoS ONE"},{"issue":"4","key":"3095_CR19","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1093\/europace\/eux087","volume":"20","author":"S Hellwig","year":"2018","unstructured":"Hellwig S, Grittner U, Audebert H, Endres M, Haeusler KG (2018) Non-vitamin K-dependent oral anticoagulants have a positive impact on ischaemic stroke severity in patients with atrial fibrillation. Europace 20(4):569\u2013574. https:\/\/doi.org\/10.1093\/europace\/eux087","journal-title":"Europace"},{"issue":"3","key":"3095_CR20","doi-asserted-by":"publisher","first-page":"106264","DOI":"10.1016\/j.jstrokecerebrovasdis.2021.106264","volume":"31","author":"I Deguchi","year":"2022","unstructured":"Deguchi I, Osada T, Takahashi S (2022) Association between oral anticoagulants and stroke severity at onset in elderly patients with cardioembolic stroke due to Non-Valvular atrial fibrillation. J Stroke Cerebrovasc Dis 31(3):106264. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2021.106264","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"3095_CR21","doi-asserted-by":"publisher","unstructured":"Garcia C, Silva M, Araujo M, Henriques M, Margarido M, Vicente P et al (2022) Admission severity of Atrial-Fibrillation-Related acute ischemic stroke in patients under anticoagulation treatment: A systematic review and Meta-Analysis. J Clin Med 11(12). https:\/\/doi.org\/10.3390\/jcm11123563","DOI":"10.3390\/jcm11123563"},{"issue":"9","key":"3095_CR22","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1161\/STROKEAHA.110.602235","volume":"42","author":"N Hannon","year":"2011","unstructured":"Hannon N, Callaly E, Moore A, Ni Chroinin D, Sheehan O, Marnane M et al (2011) Improved late survival and disability after stroke with therapeutic anticoagulation for atrial fibrillation: a population study. Stroke 42(9):2503\u20132508. https:\/\/doi.org\/10.1161\/STROKEAHA.110.602235","journal-title":"Stroke"},{"issue":"3","key":"3095_CR23","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1253\/circj.CJ-16-0707","volume":"81","author":"M Matsumoto","year":"2017","unstructured":"Matsumoto M, Sakaguchi M, Okazaki S, Hashikawa K, Takahashi T, Matsumoto M et al (2017) Relationship between infarct volume and prothrombin Time-International normalized ratio in ischemic stroke patients with nonvalvular atrial fibrillation. Circ J 81(3):391\u2013396. https:\/\/doi.org\/10.1253\/circj.CJ-16-0707","journal-title":"Circ J"},{"issue":"4","key":"3095_CR24","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s11239-018-1634-1","volume":"45","author":"C Hoyer","year":"2018","unstructured":"Hoyer C, Filipov A, Neumaier-Probst E, Szabo K, Ebert A, Alonso A (2018) Impact of pre-admission treatment with non-vitamin K oral anticoagulants on stroke severity in patients with acute ischemic stroke. J Thromb Thrombolysis 45(4):529\u2013535. https:\/\/doi.org\/10.1007\/s11239-018-1634-1","journal-title":"J Thromb Thrombolysis"},{"issue":"4","key":"3095_CR25","doi-asserted-by":"publisher","first-page":"104691","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.104691","volume":"29","author":"SF Tavares","year":"2020","unstructured":"Tavares SF, Ferreira I, Chaves V, Flores L, Correia C, Almeida J et al (2020) Acute ischemic stroke outcome and preceding anticoagulation: direct oral anticoagulants versus vitamin K antagonists. J Stroke Cerebrovasc Dis 29(4):104691. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2020.104691","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"3095_CR26","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.jocn.2021.04.027","volume":"89","author":"M Nakajima","year":"2021","unstructured":"Nakajima M, Inatomi Y, Ueda A, Ito Y, Kouzaki Y, Takita T et al (2021) Preceding direct oral anticoagulant administration reduces the severity of stroke in patients with atrial fibrillation - K-PLUS registry. J Clin Neurosci 89:106\u2013112. https:\/\/doi.org\/10.1016\/j.jocn.2021.04.027","journal-title":"J Clin Neurosci"},{"issue":"36","key":"3095_CR27","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","volume":"45","author":"IC Van Gelder","year":"2024","unstructured":"Van Gelder IC, Rienstra M, Bunting KV, Casado-Arroyo R, Caso V, Crijns H et al (2024) 2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European association for Cardio-Thoracic surgery (EACTS). Eur Heart J 45(36):3314\u20133414. https:\/\/doi.org\/10.1093\/eurheartj\/ehae176","journal-title":"Eur Heart J"},{"issue":"4","key":"3095_CR28","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1161\/CIRCULATIONAHA.123.066485","volume":"149","author":"LPT Joosten","year":"2024","unstructured":"Joosten LPT, van Doorn S, van de Ven PM, Kohlen BTG, Nierman MC, Koek HL et al (2024) Safety of switching from a vitamin K antagonist to a Non-Vitamin K antagonist oral anticoagulant in frail older patients with atrial fibrillation: results of the FRAIL-AF randomized controlled trial. Circulation 149(4):279\u2013289. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.123.066485","journal-title":"Circulation"},{"issue":"3","key":"3095_CR29","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1159\/000514155","volume":"50","author":"N Venketasubramanian","year":"2021","unstructured":"Venketasubramanian N, Anderson C, Ay H, Aybek S, Brinjikji W, de Freitas GR et al (2021) Stroke care during the COVID-19 pandemic: international expert panel review. Cerebrovasc Dis 50(3):245\u2013261. https:\/\/doi.org\/10.1159\/000514155","journal-title":"Cerebrovasc Dis"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-025-03095-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-025-03095-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-025-03095-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T02:11:48Z","timestamp":1746065508000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-025-03095-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,5]]},"references-count":29,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["3095"],"URL":"https:\/\/doi.org\/10.1007\/s11239-025-03095-1","relation":{},"ISSN":["1573-742X"],"issn-type":[{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,5]]},"assertion":[{"value":"25 March 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}